Homebusiness News

Remdesivir shortage: Cipla, Cadila ramping-up production

business | IST

Remdesivir shortage: Cipla, Cadila ramping-up production

Mini

CNBC-TV18 has learnt that Remdesivir is witnessing a shortage across major states and that is because of a sudden spurt in demand that has been seen.

There are around 6-7 companies that are licensed to sell Remdesivir in India. It includes Cadila, Cipla, Mylan, Hetero, Jubilant Lifesciences and Dr Reddy’s Laboratories (DRL).

CNBC-TV18 has learnt that Remdesivir is witnessing a shortage across major states and that is because of a sudden spurt in demand that has been seen.
Now, because of the surge that has been seen in the COVID-19 cases, all of the companies have had to ramp up demand quite substantially. The shortage is because Remdesivir takes a longer time to ramp up production.
Watch the accompanying video of CNBC-TV18’s Ekta Batra for more details.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!